{"matchedTerms": [], "ambiguousTerms": [{"searchTerm": "3350", "geneName": "HTR1A", "geneLongName": "5-HYDROXYTRYPTAMINE RECEPTOR 1A", "entrezId": 3350, "geneCategories": [{"id": "26f6a4ea7779433ea2cbf524683accf7", "name": "CELL SURFACE"}, {"id": "b258740aae5a4b0c8a0a82c3dcf01918", "name": "G PROTEIN COUPLED RECEPTOR"}, {"id": "d3ec2631e0b2434b9dcc008e793d3fa5", "name": "DRUGGABLE GENOME"}], "interactions": [{"interactionId": "ce6afb7a-5c23-45b8-a690-14382c357285", "interactionTypes": ["agonist"], "drugName": "ZALOSPIRONE", "drugConceptId": "chembl:CHEMBL3990567", "sources": ["TTD"], "pmids": [], "score": 1.1}, {"interactionId": "58bb8c9d-fbc0-4368-9a9b-95c240814086", "interactionTypes": [], "drugName": "SERTRALINE", "drugConceptId": "chembl:CHEMBL809", "sources": ["PharmGKB"], "pmids": [19590397, 18047755, 18484082, 18387740, 21688171, 19800133, 23733030], "score": 0.42}, {"interactionId": "0f03c2b6-2477-4238-9421-92e8616851c4", "interactionTypes": [], "drugName": "MILNACIPRAN", "drugConceptId": "chembl:CHEMBL259209", "sources": ["PharmGKB"], "pmids": [18484082], "score": 0.44}, {"interactionId": "b6482613-8cf0-4503-8a32-998d20a42ad4", "interactionTypes": [], "drugName": "PIROMELATINE", "drugConceptId": "chembl:CHEMBL4297523", "sources": ["TTD"], "pmids": [], "score": 0.37}, {"interactionId": "a15f27bf-7ab0-4448-9ac2-2268e49d6376", "interactionTypes": ["agonist"], "drugName": "SUMATRIPTAN", "drugConceptId": "chembl:CHEMBL128", "sources": ["TdgClinicalTrial"], "pmids": [11513839], "score": 0.16}, {"interactionId": "19be5e01-b759-4d95-9364-3b8a8b72d6b6", "interactionTypes": ["agonist"], "drugName": "FLIBANSERIN", "drugConceptId": "chembl:CHEMBL231068", "sources": ["TdgClinicalTrial", "TTD"], "pmids": [26412054, 12890707, 12177684], "score": 0.61}, {"interactionId": "e0ae445e-5bc4-4587-9dd8-5d91e41d2a6a", "interactionTypes": [], "drugName": "OXYMETAZOLINE HYDROCHLORIDE", "drugConceptId": "chembl:CHEMBL1200791", "sources": ["DTC"], "pmids": [], "score": 0.16}, {"interactionId": "2e6a8919-c545-4163-9a60-c4b36e08fe16", "interactionTypes": ["agonist"], "drugName": "PARDOPRUNOX", "drugConceptId": "chembl:CHEMBL2103832", "sources": ["TdgClinicalTrial", "ChemblInteractions"], "pmids": [], "score": 0.32}, {"interactionId": "612acbd9-5919-454e-b2b6-36d43cf0d0b0", "interactionTypes": ["agonist"], "drugName": "ZIPRASIDONE", "drugConceptId": "chembl:CHEMBL708", "sources": ["TEND"], "pmids": [12923612, 10924666, 14638642, 10516958, 11132243, 11513838, 14728084, 11910268], "score": 0.55}, {"interactionId": "514d812c-11d3-4f5c-9603-4ba188940ab0", "interactionTypes": ["agonist"], "drugName": "ERGOLOID MESYLATES", "drugConceptId": "chembl:CHEMBL2311030", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.09}, {"interactionId": "19f203ec-a759-4fb4-b591-bd8b154d1f46", "interactionTypes": ["agonist"], "drugName": "SARIZOTAN HYDROCHLORIDE", "drugConceptId": "chembl:CHEMBL2146110", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.28}, {"interactionId": "d0a725bf-af44-4ad2-a5d0-a993bea3b580", "interactionTypes": ["agonist", "partial agonist"], "drugName": "BREXPIPRAZOLE", "drugConceptId": "chembl:CHEMBL2105760", "sources": ["TdgClinicalTrial", "ChemblInteractions", "TTD"], "pmids": [24947465], "score": 0.88}, {"interactionId": "bef60c3b-14ab-4c0e-ac17-83fc88911a39", "interactionTypes": ["agonist"], "drugName": "5-MEO-DMT", "drugConceptId": "chembl:CHEMBL7257", "sources": ["DTC"], "pmids": [26477571], "score": 1.1}, {"interactionId": "a9f6dfea-5780-426f-a9de-aa0187b8977b", "interactionTypes": ["agonist", "antagonist"], "drugName": "CLOZAPINE", "drugConceptId": "chembl:CHEMBL42", "sources": ["TdgClinicalTrial", "TEND", "PharmGKB"], "pmids": [12564641, 12923612, 15213359, 25560469, 15261283, 12589516], "score": 0.17}, {"interactionId": "f13ce7aa-e876-4423-bde9-2f8b9460c9d3", "interactionTypes": [], "drugName": "FLUVOXAMINE", "drugConceptId": "chembl:CHEMBL814", "sources": ["PharmGKB"], "pmids": [19590397, 18047755, 18484082, 18387740, 21688171, 19800133, 23733030], "score": 0.74}, {"interactionId": "ee1ed8c9-a458-4ed2-8c29-2f15b7e45961", "interactionTypes": ["agonist"], "drugName": "LISURIDE", "drugConceptId": "chembl:CHEMBL157138", "sources": ["TdgClinicalTrial", "TEND"], "pmids": [2887435, 1783326, 18691132, 11224054, 1678728, 12373423], "score": 2.94}, {"interactionId": "b5862b8b-1b33-45d0-afc6-1f4cfeacf78e", "interactionTypes": ["antagonist"], "drugName": "ILOPERIDONE", "drugConceptId": "chembl:CHEMBL14376", "sources": ["TdgClinicalTrial"], "pmids": [23272794], "score": 0.15}, {"interactionId": "200104c6-6916-4a3d-84c1-e546f6108b8f", "interactionTypes": ["agonist"], "drugName": "VILAZODONE", "drugConceptId": "chembl:CHEMBL439849", "sources": ["TdgClinicalTrial", "TTD"], "pmids": [15507223, 12183683], "score": 2.21}, {"interactionId": "179d7b51-2727-4a98-a2c4-9626c53aaacd", "interactionTypes": [], "drugName": "TERTATOLOL", "drugConceptId": "chembl:CHEMBL434200", "sources": ["TTD"], "pmids": [], "score": 0.37}, {"interactionId": "5bc21043-a346-43e7-949d-fea4057936af", "interactionTypes": ["partial agonist"], "drugName": "BIFEPRUNOX", "drugConceptId": "chembl:CHEMBL218166", "sources": ["TdgClinicalTrial", "ChemblInteractions"], "pmids": [17393144, 17659474, 16237379], "score": 0.92}, {"interactionId": "99c59756-9d60-4158-b07b-bd31ca14f78f", "interactionTypes": [], "drugName": "XYLOMETAZOLINE HYDROCHLORIDE", "drugConceptId": "chembl:CHEMBL1256400", "sources": ["DTC"], "pmids": [], "score": 1.1}, {"interactionId": "1cc02e0a-1e8b-42f8-b059-0b4b0946fc6b", "interactionTypes": ["agonist", "antagonist", "partial agonist"], "drugName": "QUETIAPINE", "drugConceptId": "chembl:CHEMBL716", "sources": ["TEND", "PharmGKB"], "pmids": [22120873, 17848919, 11132243, 17563257, 12445705, 16918396], "score": 0.33}, {"interactionId": "eb35a006-9b34-460f-94e0-875ba5f9e2a6", "interactionTypes": [], "drugName": "UMESPIRONE", "drugConceptId": "chembl:CHEMBL2107677", "sources": ["TTD"], "pmids": [], "score": 0.55}, {"interactionId": "54eaad73-54f9-42fc-b1d0-0b1c770001d8", "interactionTypes": [], "drugName": "URAPIDIL", "drugConceptId": "chembl:CHEMBL279229", "sources": ["TTD"], "pmids": [], "score": 0.22}, {"interactionId": "adad1979-7467-4511-85f7-abe2e5740a5a", "interactionTypes": [], "drugName": "SARIZOTAN", "drugConceptId": "chembl:CHEMBL220808", "sources": ["TTD"], "pmids": [15298067, 15707540], "score": 1.66}, {"interactionId": "399da702-f602-430c-bb05-f5f28ac5c84f", "interactionTypes": ["partial agonist"], "drugName": "VILAZODONE HYDROCHLORIDE", "drugConceptId": "chembl:CHEMBL1615374", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.55}, {"interactionId": "dff6a03f-10f1-4969-8cc5-8625c2e96bae", "interactionTypes": ["agonist"], "drugName": "PICLOZOTAN", "drugConceptId": "chembl:CHEMBL345237", "sources": ["ChemblInteractions"], "pmids": [], "score": 1.1}, {"interactionId": "0259f20e-34ac-4837-b479-6bcdd85366fb", "interactionTypes": [], "drugName": "METHAMPHETAMINE", "drugConceptId": "chembl:CHEMBL1201201", "sources": ["PharmGKB"], "pmids": [19747927], "score": 0.08}, {"interactionId": "318bf832-5a6e-4ed4-b32c-bc6c94bb07a1", "interactionTypes": ["antagonist"], "drugName": "ROBALZOTAN", "drugConceptId": "chembl:CHEMBL1628569", "sources": ["ChemblInteractions"], "pmids": [12726821, 9886765], "score": 3.31}, {"interactionId": "827d0fba-1450-4a68-b098-4ab528ccf72b", "interactionTypes": ["agonist"], "drugName": "NARATRIPTAN", "drugConceptId": "chembl:CHEMBL1278", "sources": ["TdgClinicalTrial"], "pmids": [14728705, 11152011], "score": 0.83}, {"interactionId": "09438d76-b94a-4421-b1a2-dba837f686df", "interactionTypes": [], "drugName": "MIRTAZAPINE", "drugConceptId": "chembl:CHEMBL654", "sources": ["TEND"], "pmids": [], "score": 0.06}, {"interactionId": "3ea0319d-4f36-4e6b-bc5c-b6e532f5322f", "interactionTypes": ["antagonist"], "drugName": "LECOZOTAN HYDROCHLORIDE", "drugConceptId": "chembl:CHEMBL2107349", "sources": ["ChemblInteractions"], "pmids": [], "score": 1.1}, {"interactionId": "a14418f1-b119-4079-8bb3-d34def94dc45", "interactionTypes": ["agonist", "antagonist", "inhibitor"], "drugName": "OLANZAPINE", "drugConceptId": "chembl:CHEMBL715", "sources": ["TdgClinicalTrial", "PharmGKB"], "pmids": [22120873, 17848919, 25032030], "score": 0.08}, {"interactionId": "deb65a3a-85b8-43da-98d1-9203e4c22e0e", "interactionTypes": [], "drugName": "ELTOPRAZINE", "drugConceptId": "chembl:CHEMBL282614", "sources": ["TTD"], "pmids": [], "score": 0.37}, {"interactionId": "d3fb4c8b-81cf-4159-872e-39828203f5cb", "interactionTypes": ["antagonist"], "drugName": "RISPERIDONE", "drugConceptId": "chembl:CHEMBL85", "sources": ["PharmGKB"], "pmids": [22120873, 11132243], "score": 0.06}, {"interactionId": "567a2d71-582e-44ff-a1b4-5c7fca26b520", "interactionTypes": ["agonist"], "drugName": "NALUZOTAN", "drugConceptId": "chembl:CHEMBL209821", "sources": ["TdgClinicalTrial", "ChemblInteractions"], "pmids": [18344738, 17495280, 17263189], "score": 5.52}, {"interactionId": "15d27ede-fe84-4880-8569-e52b84cec29f", "interactionTypes": ["agonist"], "drugName": "VORTIOXETINE", "drugConceptId": "chembl:CHEMBL2104993", "sources": ["TdgClinicalTrial"], "pmids": [21486038, 16290165], "score": 0.55}, {"interactionId": "cfcb5d32-3a41-4064-bdca-912edb1c491f", "interactionTypes": ["agonist", "antagonist", "partial agonist"], "drugName": "ARIPIPRAZOLE", "drugConceptId": "chembl:CHEMBL1112", "sources": ["TdgClinicalTrial", "ChemblInteractions", "TEND"], "pmids": [15257633, 15862515, 12063084, 14647959, 14709325, 26346901], "score": 0.83}, {"interactionId": "fda1c76c-ca17-4bfc-ae7e-5bf32d34d20e", "interactionTypes": ["antagonist", "partial agonist"], "drugName": "TRAZODONE", "drugConceptId": "chembl:CHEMBL621", "sources": ["TdgClinicalTrial", "TEND", "TTD"], "pmids": [29056986, 7855217, 15888508, 12127910], "score": 0.59}, {"interactionId": "ba15c02d-5bb6-4b4d-b806-b8f92b252326", "interactionTypes": [], "drugName": "FLUOXETINE", "drugConceptId": "chembl:CHEMBL41", "sources": ["PharmGKB"], "pmids": [19590397, 16302021], "score": 0.12}, {"interactionId": "01d356b6-f028-484f-ba26-d5f8919e69e9", "interactionTypes": [], "drugName": "PAROXETINE", "drugConceptId": "chembl:CHEMBL490", "sources": ["PharmGKB"], "pmids": [19590397, 18047755, 18484082, 18387740, 21688171, 19800133, 23733030], "score": 0.37}, {"interactionId": "0f82a3e0-7387-40e5-90c4-ec06e5100821", "interactionTypes": ["agonist"], "drugName": "ZOLMITRIPTAN", "drugConceptId": "chembl:CHEMBL1185", "sources": ["TdgClinicalTrial"], "pmids": [11513839, 9399012, 29352859], "score": 0.88}, {"interactionId": "d93b245a-7cdf-4f60-b911-417756e8f9bd", "interactionTypes": ["agonist", "antagonist"], "drugName": "ASENAPINE", "drugConceptId": "chembl:CHEMBL3187365", "sources": ["TdgClinicalTrial"], "pmids": [18308814, 10592235], "score": 0.18}, {"interactionId": "b5d1fe63-1cc3-4eae-8b69-5abc0d8e65db", "interactionTypes": [], "drugName": "AMISULPRIDE", "drugConceptId": "chembl:CHEMBL243712", "sources": ["PharmGKB"], "pmids": [22120873], "score": 0.25}, {"interactionId": "502596c3-6b57-4510-94fa-d75ec44fed53", "interactionTypes": ["antagonist"], "drugName": "LURASIDONE", "drugConceptId": "chembl:CHEMBL1237021", "sources": ["TdgClinicalTrial", "PharmGKB"], "pmids": [31636356, 23545936], "score": 0.88}, {"interactionId": "a5ecc4de-3b13-4725-a5f6-de63a087f4a4", "interactionTypes": ["partial agonist"], "drugName": "BUSPIRONE HYDROCHLORIDE", "drugConceptId": "chembl:CHEMBL1200399", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.37}, {"interactionId": "1b767962-e188-4730-9fe6-1bd912b2db35", "interactionTypes": ["antagonist"], "drugName": "GSK163090", "drugConceptId": "chembl:CHEMBL1631540", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.28}, {"interactionId": "c4780e18-8ff8-4b58-8cd7-5e09eb176504", "interactionTypes": [], "drugName": "GEPIRONE", "drugConceptId": "chembl:CHEMBL284092", "sources": ["TdgClinicalTrial", "TTD"], "pmids": [], "score": 2.21}, {"interactionId": "f19c956f-d698-49a8-8475-72f6910ffd20", "interactionTypes": ["agonist"], "drugName": "VORTIOXETINE HYDROBROMIDE", "drugConceptId": "chembl:CHEMBL2107387", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.37}, {"interactionId": "2b6e3918-59c8-4e93-a9b7-47eeea0617ae", "interactionTypes": ["partial agonist"], "drugName": "ARIPIPRAZOLE LAUROXIL", "drugConceptId": "chembl:CHEMBL2219425", "sources": ["ChemblInteractions"], "pmids": [], "score": 0.37}, {"interactionId": "c0c47266-f000-4a68-a129-ded5de244844", "interactionTypes": ["agonist"], "drugName": "OSEMOZOTAN", "drugConceptId": "chembl:CHEMBL1742408", "sources": ["TdgClinicalTrial", "ChemblInteractions", "TTD"], "pmids": [], "score": 3.31}, {"interactionId": "dc2be972-0f8b-497e-b6ea-bc300da93edd", "interactionTypes": ["agonist", "partial agonist"], "drugName": "BUSPIRONE", "drugConceptId": "chembl:CHEMBL49", "sources": ["TdgClinicalTrial", "TEND", "TTD"], "pmids": [10064829, 10428422, 10215901, 14769835, 11752352, 10221756, 10027850], "score": 1.58}, {"interactionId": "46296abc-c963-444a-b8e1-cfdf302f00a9", "interactionTypes": ["agonist"], "drugName": "BEFIRADOL", "drugConceptId": "chembl:CHEMBL45305", "sources": ["ChemblInteractions"], "pmids": [], "score": 1.1}, {"interactionId": "b77f9c11-a278-42ab-bd82-5d6fba0576c2", "interactionTypes": [], "drugName": "XALIPRODEN", "drugConceptId": "chembl:CHEMBL1512580", "sources": ["TdgClinicalTrial", "TTD"], "pmids": [], "score": 2.21}, {"interactionId": "dbc81da8-2914-4317-bcf8-28ce3a4db5d4", "interactionTypes": ["agonist"], "drugName": "ROTIGOTINE", "drugConceptId": "chembl:CHEMBL1303", "sources": ["TEND"], "pmids": [18691132, 18704368], "score": 0.66}, {"interactionId": "933c7729-6791-4af4-b0c9-fb769c2b4070", "interactionTypes": ["agonist"], "drugName": "METHYSERGIDE", "drugConceptId": "chembl:CHEMBL485253", "sources": ["TdgClinicalTrial", "TEND"], "pmids": [11049861, 14581123, 14517765, 14501155, 1838579], "score": 0.77}]}, {"searchTerm": "3350", "geneName": "ENO1", "geneLongName": "ENOLASE 1", "entrezId": 2023, "geneCategories": [{"id": "26f6a4ea7779433ea2cbf524683accf7", "name": "CELL SURFACE"}, {"id": "4866b8ad-3c3e-4c04-802f-587f697212db", "name": "ENZYME"}], "interactions": []}], "unmatchedTerms": []}